# Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon

> **NCT05069597** · PHASE4 · COMPLETED · sponsor: **AbbVie** · enrollment: 30 (actual)

## Conditions studied

- Cystic Fibrosis
- Chronic Pancreatitis

## Interventions

- **DRUG:** CREON

## Key facts

- **NCT ID:** NCT05069597
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-14
- **Primary completion:** 2023-07-07
- **Final completion:** 2023-08-28
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05069597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05069597, "Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05069597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*